STERIS agrees to buy Xodus Medical for USD 2.10 billion: what it means for STERIS stock

Published on 10/18/2026 at 12:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Xodus is projected to add USD 245 million in 2026 revenue. For STERIS stock, closing is planned by December 31, 2026, subject to approvals.

Acquisition scale and upcoming dates

On October 12, 2026, STERIS said Xodus would add USD 245 million in annual revenue.
Xodus is projected to contribute USD 135 million in adjusted EBIT for calendar 2026.
STERIS had a USD 21.7 billion market capitalization as of October 16, 2026.

Fotorealistische Sterilisationsabteilung mit Autoklav und Instrumententabletts im Krankenhaus — Steris plc IE00BFY8C754 zeigt fotorealistisch eine moderne Krankenhaus-Sterilisationsabteilung mit Edelstahl-Autoklaven und Instrumentenwagen, Illustration mit AI erstellt.

STERIS plc (ISIN IE00BFY8C754) agreed on October 12, 2026, to acquire Xodus Medical for USD 2.10 billion, according to STERIS plc. The transaction is expected to close by December 31, 2026, subject to regulatory approvals and customary conditions.

What does the deal mean for margins?

The acquisition gives STERIS a larger consumables offering for operating rooms. Xodus is projected to generate USD 245 million in calendar 2026 revenue and USD 135 million in adjusted EBIT, according to STERIS plc. The projected revenue equals 16.4 percent of STERIS's USD 1.49 billion fiscal first-quarter revenue, reported for the quarter ended June 30, 2026, by Benzinga.

Three milestones and their figures

On August 5, 2026, STERIS reported fiscal first-quarter revenue of USD 1.49 billion and adjusted earnings per share of USD 2.59, according to Benzinga. On August 7, 2026, UBS reduced its price target from USD 275.00 to USD 270.00 while keeping a Buy rating, as reported by MarketBeat. On October 12, 2026, the company announced the USD 2.10 billion Xodus agreement.

Which dates come next?

STERIS is estimated to report fiscal second-quarter 2027 results on November 4, 2026, after the market close, with a conference call scheduled for November 5, 2026, according to MarketBeat. The Xodus transaction is planned to close by December 31, 2026, and STERIS said it will provide a revised fiscal 2027 outlook after closing.

Market value and investor scale

STERIS had a USD 21.7 billion market capitalization as of October 16, 2026. The company operates across Healthcare, Applied Sterilization Technologies and Life Sciences, with products and services centered on infection prevention and procedural care. The further course of trading is shown by the continuously updated real-time quote of STERIS stock.